BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35819061)

  • 1. Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis.
    da Costa WL; Tran Cao HS; Gu X; Massarweh NN
    J Surg Oncol; 2022 Nov; 126(6):986-994. PubMed ID: 35819061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
    da Costa WL; Tran Cao HS; Gu X; Massarweh NN
    Ann Surg; 2022 Mar; 275(3):415-421. PubMed ID: 35120060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis.
    Alaimo L; Moazzam Z; Lima HA; Endo Y; Woldesenbet S; Ejaz A; Cloyd J; Guglielmi A; Ruzzenente A; Pawlik TM
    Ann Surg Oncol; 2023 Aug; 30(8):4799-4808. PubMed ID: 37029867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients.
    da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Massarweh NN
    J Surg Res; 2022 Nov; 279():256-264. PubMed ID: 35797753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
    Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data Base.
    Mirkin KA; Hollenbeak CS; Wong J
    Int J Surg; 2016 Oct; 34():96-102. PubMed ID: 27573691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis.
    da Costa WL; Tran Cao HS; Sheetz KH; Gu X; Norton EC; Massarweh NN
    Ann Surg Oncol; 2021 Jun; 28(6):3186-3195. PubMed ID: 33174146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
    Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
    J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Int J Surg; 2018 Apr; 52():221-228. PubMed ID: 29425826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
    Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
    Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Arrington AK; O'Grady C; Schaefer K; Khreiss M; Riall TS
    Ann Surg; 2020 Sep; 272(3):438-446. PubMed ID: 32740236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma.
    da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Carrott PW; Massarweh NN
    Ann Thorac Surg; 2022 Jan; 113(1):279-285. PubMed ID: 33484675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer.
    Portuondo JI; Tran Cao HS; da Costa WL; Sada YH; Harris AHS; Massarweh NN
    J Surg Oncol; 2021 May; 123(8):1724-1735. PubMed ID: 33721353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer.
    Kamarajah SK; Newton N; Navidi M; Wahed S; Immanuel A; Hayes N; Griffin SM; Phillips AW
    Dis Esophagus; 2020 Aug; 33(8):. PubMed ID: 31950184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
    Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
    J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.